Daisuke Kotani, GI Medical Oncologist, Chief Physician at the Department of Gastrointestinal Oncology at the National Cancer Center Hospital East, Japan, shared a post on X:
“Position statement on ADCs in solid tumors
The recent pivotal studies and key ongoing studies on ADCs are summarized in Table 1 and 2.”
Title: Antibody–drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation
Authors: S. Peters, M.-L. Meyer, Fabrice André, G. Argilés, A.A. Azizi, S. Banerjee, S. Burgers, Giuseppe Curigliano, J.Z. Drago, E. Fontana, E.B. Garon, N. Klümper, L. Le Bescond, F. Lopez-Rios, G. Mountzios, A. Passaro, L. Paz-Ares, B. Pistilli, T. Powles, N. Reguart, J. Remon, T. Schmelzle, M.J. Skynner, E. Smit, E. Smyth, C. Swanton, E. Van Cutsem, S. Loi, R.A. Stahel
Read the Full Article on ESMO Open
Other posts featuring Daisuke Kotani on OncoDaily.
